The effects of darifenacin and tolterodine on heart rate (HR) in patients with overactive bladder (OAB)
Olshansky B1, Foote J2, Arguinzoniz M3, Lheritier K3, Quebe-Fehling E3, Steel M3 1. University of Iowa Hospitals, Iowa, IA, USA, 2. Midtown Urology and Surgical Center, Atlanta, GA, USA, 3. Novartis Pharma AG, Basel, Switzerland
|
|
Abstract 124
|
|
|
Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium
Scientific Podium Poster Session 14
|
|
|
Friday 1st December 2006 |
|
|
09:07 - 09:15 |
|
|